lung tissue
MRC-5
other disease animal model
fibrosis (promotes); proliferation (promotes); migration (promotes); autophagy (inhibits); mRNA stability (promotes); other pathway/process (other)
RT-qPCR; Nuclear-Cytoplasmic Fractionation; RIP (RNA Immunoprecipitation); Transfection; CCK8; Wound Healing Assay; IF (Immunofluorescence); Western Blot; In Vivo Animal Model; H&E Staining
-
circFOXP1 is up-regulated in pulmonary fibrosis models and acts as a profibrotic circRNA. hucMSCs treatment downregulates circFOXP1, which reduces HuR stability and nucleocytoplasmic shuttling, decreases EZH2/STAT1/FOXK1, enhances autophagy, and thereby attenuates pulmonary fibrosis.
0.5706
hucMSCs Treatment Ameliorated Pulmonary Fibrosis via Downregulating the circFOXP1-HuR-EZH2/STAT1/FOXK1 Autophagic Axis.
biological research